Overall Survival With Palbociclib and Aromatase Inhibitor Versus Aromatase Inhibitor Alone in Older Patients With HR+/HER2− Metastatic Breast Cancer.
Saved in:
| Title: | Overall Survival With Palbociclib and Aromatase Inhibitor Versus Aromatase Inhibitor Alone in Older Patients With HR+/HER2− Metastatic Breast Cancer. |
|---|---|
| Authors: | Brufsky, Adam M.1 (AUTHOR), Sandin, Rickard2 (AUTHOR), Stergiopoulos, Stella3 (AUTHOR) stella.stergiopoulos@pfizer.com, Chen, Connie3 (AUTHOR), Karanth, Siddharth4 (AUTHOR), Li, Benjamin3 (AUTHOR), Esterberg, Elizabeth4 (AUTHOR), Makari, Doris3 (AUTHOR), Candrilli, Sean D.4 (AUTHOR), Goyal, Ravi K.4 (AUTHOR), Rugo, Hope S.5 (AUTHOR) |
| Source: | Cancer Medicine. Apr2025, Vol. 14 Issue 7, p1-18. 18p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.70719 |
